Home Trending Stocks Why Ocugen, Inc. (OCGN) stock is popping high today?

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge of 7.83% to reach $10.33 a share at the time of this writing. OCGN stock was down for the past three days and dropped 12.19% at the previous closing. Let’s discuss more Ocugen stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What’s Happening?

Ocugen, Inc is a clinical-stage biopharmaceutical company working on the development of gene therapies in order to cure diseases related to blindness. Investors are eyeing OCGN stock as it will announce its earnings report today. OCGN per share price touch a six-month high on Monday but then it went down for the next three days before today’s rally.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Recent moves:

Previous data shows that the performance of Ocugen stock is not so much satisfactory as its earnings surprise history disappointed the analysts’ expectations in the past three quarters. The average negative surprise of OCGN stock was 274.44%.

Pre Clinical Study of OCU200:

On May 7, 2021, OCGN stock reported a pre-clinical study of OCU200 in which the efficacy of in-vitro and in-vivo models for ocular neovascular diseases was evaluated. The data showed that the OCU200 has the ability to show potential benefits beyond anti-VEGF therapy and could be effective for patients who are not getting benefits from the current therapies. The CEO said that they are looking forward to advancing their programs and working hard for the development of new treatment options for the patients.

Ocugen contribution against COVID-19:

Ocugen stock is also involved in the battle against COVID-19 as it announced a partnership agreement with Bharat Biotech in the last month of 2020 in order to commercialize the coronavirus vaccine Covaxin in the United States. Remember that Covaxin has already got authorization in India, a country in which COVID-19 is at its peak nowadays. If Covaxin gets EUA or FDA approval, then OCGN stock will get 45% profit from the sales of Covaxin in the U.S.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

OCGN stock is hot among investors in today’s date ahead of its first-quarter financial results. The earnings surprise history for the past three quarters is disappointing and upcoming financial results would further clarify the position of OCGN stock. Hence deep analysis is necessary before adding Ocugen stock to the portfolio.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam